Katharina Jundt1, Kathrin Schreyer, Klaus Friese, Ursula Peschers. 1. Department of Obstetrics and Gynecology, Campus Innenstadt, Beckenbodenzentrum der LMU, Maistrasse, Ludwig-Maximilians-Universitaet, Maistr. 11, 80337 Munich, Germany. katharina.jundt@med.uni-muenchen.de
Abstract
PURPOSE: To evaluate how many patients with overactive bladder still take their prescribed medication at least 12 months later and to find out the reasons for discontinuation of the therapy. METHODS: Two hundred and ten patients who had received a prescription for anticholinergic medication were contacted by telephone 12-46 months later. RESULTS: Out of 210 eligible patients 132 (63%) could be contacted and gave consent to participate in the study. 38% of them still took their medication after at least 12 months. 17% were continent or much improved, 13% a little improved, 8% were not improved, although still taking their medication. 62% did not take the original medication any more. 10% had never started with the medication, 42% took the medication for 3 months and 8% for 4-12 months. 25% had changed to another anticholinergic drug. CONCLUSION: Anticholinergic therapy is often discontinued by patients and doctors. Patients with OAB therefore need counselling and follow-up in the long term to make sure that alternative treatment is offered if anticholinergic treatment does not work.
PURPOSE: To evaluate how many patients with overactive bladder still take their prescribed medication at least 12 months later and to find out the reasons for discontinuation of the therapy. METHODS: Two hundred and ten patients who had received a prescription for anticholinergic medication were contacted by telephone 12-46 months later. RESULTS: Out of 210 eligible patients 132 (63%) could be contacted and gave consent to participate in the study. 38% of them still took their medication after at least 12 months. 17% were continent or much improved, 13% a little improved, 8% were not improved, although still taking their medication. 62% did not take the original medication any more. 10% had never started with the medication, 42% took the medication for 3 months and 8% for 4-12 months. 25% had changed to another anticholinergic drug. CONCLUSION: Anticholinergic therapy is often discontinued by patients and doctors. Patients with OAB therefore need counselling and follow-up in the long term to make sure that alternative treatment is offered if anticholinergic treatment does not work.